Head and neck MRI-based T stage and [^18F]FDG PET/CT-based N/M stage improved prognostic stratification in primary nasopharyngeal carcinoma

[1]  Dong Jin Lee,et al.  The value of CT, MRI, and PET-CT in detecting retropharyngeal lymph node metastasis of head and neck squamous cell carcinoma , 2020, BMC Medical Imaging.

[2]  T. Yen,et al.  Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  C. Rowe,et al.  High performance plasma amyloid-β biomarkers for Alzheimer’s disease , 2018, Nature.

[4]  G. Jin,et al.  Comparison of Gadolinium-enhanced MRI and 18FDG PET/PET-CT for the diagnosis of brain metastases in lung cancer patients: A meta-analysis of 5 prospective studies , 2017, Oncotarget.

[5]  Jeong Hyun Lee,et al.  Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study. , 2016, European journal of cancer.

[6]  James Brierley,et al.  Improving the TNM classification: Findings from a 10‐year continuous literature review , 2014, International journal of cancer.

[7]  M. Hornbrook,et al.  Positron emission tomography and stage migration in head and neck cancer. , 2013, JAMA otolaryngology-- head & neck surgery.

[8]  Jin-Ching Lin,et al.  Current management of nasopharyngeal cancer. , 2012, Seminars in radiation oncology.

[9]  C. Qian,et al.  The prevalence and prevention of nasopharyngeal carcinoma in China , 2011, Chinese journal of cancer.

[10]  Johan Bussink,et al.  Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  Chun-Ta Liao,et al.  Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  L. Balestreri,et al.  Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. , 2008, Radiology.

[13]  M. Senda,et al.  Accuracy of whole-body FDG-PET/CT for detecting brain metastases from non-central nervous system tumors , 2008, Annals of nuclear medicine.

[14]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[15]  I. Bradbury,et al.  Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. , 2007, Health technology assessment.

[16]  J. Roh,et al.  Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  C. Timon,et al.  Evaluation of the impact of addition of PET to CT and MR scanning in the staging of patients with head and neck carcinomas , 2006, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[18]  David Schuster,et al.  F‐18 FDG PET‐CT fusion in radiotherapy treatment planning for head and neck cancer , 2005, Head & neck.

[19]  T. Yen,et al.  Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography. , 2005, International journal of radiation oncology, biology, physics.

[20]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[21]  Jacob Cohen.  A Coefficient of Agreement for Nominal Scales , 1960 .

[22]  J. Cooper.  Ajcc Cancer Staging Manual , 1997 .